Delivery Order SPE2DB22D2007-SPE2DB26FH6LW
- Not listed
- The Defense Logistics Agency awarded a $5,078.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets) in quantities of 20 units. This contract represents a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 40-count packages) valued at $5,124.16. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 21, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively...
- The Defense Logistics Agency awarded a delivery order valued at $10,173.33 to AmerisourceBergen Drug Corp for the supply of Lonsurf (20 mg-8.19 mg tablets, quantity 60) under a firm fixed price contract type. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, represents a non-set-aside competitive procurement. This delivery order is executed under AmerisourceBergen's Indefinite Delivery Contract (IDC) designated SPE2DX with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Lonsurf (20 mg–8.19 mg tablets) in a 60-count package with a ceiling value of $10,173.33 under firm fixed-price terms. This is a non-set-aside competitive award with an ultimate completion date of October 3, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $10,248.32 and firm fixed pricing. The contract is non-set-aside and represents a competitively awarded delivery order, with an ultimate completion date of November 24, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Lonsurf (a cancer treatment medication) in tablet form, with a contract ceiling value of $3,406.92 and an ultimate completion date of November 13, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a continuation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of LONSURF (15 mg-6.14 mg tablets) in a quantity of 40 units, with a ceiling value of $5,124.17 and firm fixed pricing. This delivery order, which is not set-aside, is scheduled for completion by August 28, 2025, with performance occurring at the vendor's location in Conshohocken, Pennsylvania. The award represents a competitive procurement under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LONSURF (20 mg-8.19 mg tablets, 20-count) on October 22, 2025, with a ceiling value of $6,813.86 and an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive pharmaceutical supply relationship with the federal government. AmerisourceBergen Drug Corp, headquartered...
- The Defense Logistics Agency awarded a delivery order valued at $3,406.92 to AmerisourceBergen Drug Corp for LONSURF 20 mg-8.19 mg tablets (quantity 20) on October 20, 2025, with completion expected by November 10, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6.76K to AmerisourceBergen Drug Corp for the supply of LONSURF 20 mg–8.19 mg tablets (40-count packages). This non-competitive, firm fixed-price delivery order was issued on June 16, 2025, with an ultimate completion date of July 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. LONSURF is a combination chemotherapy medication used in cancer treatment, reflecting the breadth of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6LWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Lonsurf (15 mg-6.14 mg tablets, 60-count packages) with a ceiling value of $23,055.99 under a firm fixed-price contract. This is a non-set-aside, competitively awarded delivery order supporting federal pharmaceutical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies globally to support military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal vendor for the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical procurement requirements, including specialty medications, brand-name and generic drugs, and specialized medical supplies across multiple therapeutic domains. This delivery order for Lonsurf, an oncology medication, reflects the company's ongoing role in supporting Defense Health Agency and other federal healthcare systems through its flexible and comprehensive contract vehicle designed to meet military medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.1k | 10/27/25 |